Amphastar Pharmaceuticals (AMPH) Current Taxes: 2013-2025
Historic Current Taxes for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to $5.6 million.
- Amphastar Pharmaceuticals' Current Taxes rose 339.73% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 339.73%. This contributed to the annual value of $9.7 million for FY2024, which is 500.62% up from last year.
- Amphastar Pharmaceuticals' Current Taxes amounted to $5.6 million in Q3 2025, which was up 436.99% from $1.0 million recorded in Q2 2025.
- Over the past 5 years, Amphastar Pharmaceuticals' Current Taxes peaked at $31.1 million during Q3 2023, and registered a low of $597,000 during Q2 2022.
- In the last 3 years, Amphastar Pharmaceuticals' Current Taxes had a median value of $5.9 million in 2024 and averaged $9.3 million.
- Its Current Taxes has fluctuated over the past 5 years, first spiked by 2,864.15% in 2023, then crashed by 95.88% in 2024.
- Amphastar Pharmaceuticals' Current Taxes (Quarterly) stood at $9.1 million in 2021, then crashed by 49.66% to $4.6 million in 2022, then plummeted by 64.80% to $1.6 million in 2023, then surged by 500.62% to $9.7 million in 2024, then soared by 339.73% to $5.6 million in 2025.
- Its Current Taxes stands at $5.6 million for Q3 2025, versus $1.0 million for Q2 2025 and $15.1 million for Q1 2025.